Benutzer: Gast  Login
Titel:

From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease.

Dokumenttyp:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Article
Autor(en):
Friedman, DJ; Künzli, BM; A-Rahim, YI; Sévigny, J; Berberat, PO; Enjyoji, K; Csizmadia, E; Friess, H; Robson, SC
Abstract:
CD39/ENTPD1 hydrolyzes proinflammatory nucleotides to generate adenosine. As purinergic mediators have been implicated in intestinal inflammation, we hypothesized that CD39 might protect against inflammatory bowel disease. We studied these possibilities in a mouse model of colitis using mice with global CD39 deletion. We then tested whether human genetic polymorphisms in the CD39 gene might influence susceptibility to Crohn's disease. We induced colitis in mice using Dextran Sodium Sulfate (DSS)...     »
Zeitschriftentitel:
Proc Natl Acad Sci U S A
Jahr:
2009
Band / Volume:
106
Heft / Issue:
39
Seitenangaben Beitrag:
16788-93
Sprache:
eng
Volltext / DOI:
doi:10.1073/pnas.0902869106
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/19805374
Print-ISSN:
0027-8424
TUM Einrichtung:
Chirurgische Klinik und Poliklinik
 BibTeX